Cao Xingyu
- 3 Baik • 1 ulasan
- 27 tahun pengalaman
- China, Pequim, Lu Daopei Hematology Hospital
Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.
He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.
He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.
Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.
He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.
He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).
Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.
She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.
Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.
Dr. Spielberg adalah seorang onkohematolog berdedikasi di Pusat Medis Assuta, yang berspesialisasi dalam gangguan darah seperti anemia aplastik.
Dr. Irina Zaidman spesialis dalam transplantasi sumsum tulang pediatrik – sebuah perawatan kritis untuk anemia aplastik – di Hadassah Medical Center.
Telah melakukan lebih dari 3.500 transplantasi sumsum tulang – diakui oleh Forbes sebagai salah satu dokter terbaik pada tahun 2018.
Profesor Bosch adalah pemimpin ternama di dunia dalam bidang Leukemia Limfositik Kronis (CLL), dengan lebih dari 100 artikel yang diterbitkan dan partisipasi berkelanjutan dalam 80+ uji klinis.
Prof. Dr. Serdar Bedii Omay telah menerbitkan lebih dari 65 artikel ilmiah tentang hematologi – berfokus pada perawatan tingkat lanjut di Rumah Sakit Emsey.
Dr. Apak berspesialisasi dalam hematologi-onkologi anak dengan pengalaman lebih dari 30 tahun, berfokus pada transplantasi sumsum tulang dan terapi sel CAR-T di Rumah Sakit Universitas Biruni.
Associate Professor Rafet Eren spesialis dalam hematologi dengan 50+ publikasi di jurnal internasional, mencerminkan keahlian mendalam dalam gangguan darah.
Spesialis dalam leukemia kronis dan penyakit mieloproliferatif, Dr. Dogu membawa keahlian hematologi yang luas ke Liv Hospital Ulus.
Prof. Baytan berspesialisasi dalam hematologi dan onkologi pediatrik, dengan fokus pada kanker masa kanak-kanak dan transplantasi sumsum tulang di Rumah Sakit Emsey.
Profesor Madya Ali Hakan Kaya berspesialisasi dalam hematologi dan transplantasi sel punca, dengan pelatihan ekstensif di rumah sakit terkemuka di Turki.
Spesialis dalam gangguan kegagalan sumsum tulang, Dr. Itir Sirinoglu Temiz memimpin departemen hematologi di Rumah Sakit Liv Vadistanbul.
Prof. Dr. Osman Ilhan adalah bagian dari tim yang melakukan transplantasi sel punca sumsum tulang pertama di Turki. Beliau membawa lebih dari 50 tahun keahlian hematologi ke Rumah Sakit Swasta Koru Ankara.
Ahli hematologi-onkologi anak yang berspesialisasi dalam anemia aplastik dan transplantasi sumsum tulang.
Spesialis dalam anemia aplastik dengan keahlian dalam transplantasi sumsum tulang – kunci utama untuk menangani kasus yang parah.